The up-regulation of IL-7 signaling in IBD had a worse treatment-refractory disease course, probably due to enriched pool of antigen-specific memory T cells which, upon future re-encounter with antigen, would facilitate faster and more potent response from CD8 effector cells [37]. The gene discussed is CD8A; the disease is inflammatory bowel disease.